Pisick, E., Rothe, M., Garrett-Mayer, E., Reynolds, C. M., Adesunloye, B., Thota, R., … Schilsky, R. L. (2026). Abstract CT211: Palbociclib (P) in patients (pts) with lung cancer (LC) with CCND1 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. In Cancer Research (Vol. 86, pp. CT211–CT211). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-ct211

Pisick, Evan, Michael Rothe, Elizabeth Garrett-Mayer, Christopher M. Reynolds, Bamidele Adesunloye, Ramya Thota, Kathryn F. Mileham, et al. “Abstract CT211: Palbociclib (P) in patients (pts) with lung cancer (LC) with CCND1 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.” In Cancer Research, 86:CT211–CT211. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-ct211.

Pisick E, Rothe M, Garrett-Mayer E, Reynolds CM, Adesunloye B, Thota R, et al. Abstract CT211: Palbociclib (P) in patients (pts) with lung cancer (LC) with CCND1 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. CT211–CT211.

Pisick, Evan, et al. “Abstract CT211: Palbociclib (P) in patients (pts) with lung cancer (LC) with CCND1 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.” Cancer Research, vol. 86, no. 8_Supplement, American Association for Cancer Research (AACR), 2026, pp. CT211–CT211. Crossref, doi:10.1158/1538-7445.am2026-ct211.

Pisick E, Rothe M, Garrett-Mayer E, Reynolds CM, Adesunloye B, Thota R, Mileham KF, Lynch K, Sanborn RE, Cannon TL, Moyers JT, Tu J, Akce M, Gregory A, Hinshaw DC, Grantham GN, Halabi S, Schilsky RL. Abstract CT211: Palbociclib (P) in patients (pts) with lung cancer (LC) with CCND1 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Cancer Research. American Association for Cancer Research (AACR); 2026. p. CT211–CT211.